In the past few weeks, a disconnect has emerged: Markets are rising, while COVID-19-related content seems to have reached a plateau. COVID content may be hard-pressed to drop further, considering the rising US and global caseload.
Volume of COVID-19-related data identified by five key signals has declined after peaking in late March. The Response Signal increased to 8% of all COVID-tagged content this week, up from 6%.
After claiming an increased share of COVID-19-related content in recent weeks, the "Other Categories" group encompassing 20 SASB factors looks to have set a high water mark from which it is receding. The primary six categories have an enduring hold on COVID-19-related data.
Governance topics saw a gain in the past week, while the longer view shows a fairly stable relationship between E, S, & G.
US new cases continue to dwarf China and Developed Europe, yet COVID-19-related conversation in the U.S. has not meaningfully increased.
Health Care Distributors, Cruise Lines, and Meat, Dairy & Poultry, received the most COVID-19 attention among industries, preserving their status quo at the top of this list.
The race for a vaccine continues on all continents, with Indian firm Cadila Healthcare Ltd approved by the Drug Controller General of India (DCGI) to undertake human clinical trials of a vaccine candidate.
Continuing with a focus on racial equality, we again highlight key recent Spotlight Events. Racial justice data shows that protests are beyond BLM and the US: In Australia, indigenous rights are discussed, and in Canada, RBC has set new executive diversity targets, while in Zimbabwe a soft drink producer is under scrutiny.
This global mapping by COVID-19 coverage, aggregated by corporate country of domicile, shows relative volume by country of different COVID-19 signals. This week there are rising volumes in Nigeria and South Africa, both of which also saw double-digit COVID-19 confirmed case growth, of 12% and 35%, respectively, according to JHU numbers.